CASI Pharmaceuticals, Inc (DE)

Ownership Transactions Reported by 8 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
9620 Medical Center Dr, Ste 300, Rockville, Maryland

There are no Buy or Sell transactions made by insiders since 9/12/2023

CASI Pharmaceuticals, Inc (DE) executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rajesh Shrotriya Director May 25, 2022
Alexander A. Zukiwski EVP and Chief Medical Officer Sep 7, 2022
Franklin Salisbury Director May 25, 2022
Yue Alexander Wu Director May 25, 2022
Wei-Wu He Chairman and CEO, Director, 10%+ Owner Jun 13, 2022
James Huang Director Sep 6, 2022
Quan Zhou Director May 25, 2022
Larry Zhang President Jul 24, 2021

Recent Insider Transactions by Companies or Individuals for CASI Pharmaceuticals, Inc (DE)

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.